Ziopharm Oncology buy exploration
Start price
22.04.16
/
50%
€7.12
Target price
19.07.16
€10.10
Performance (%)
-43.45%
End price
19.07.16
€4.03
Summary
This prediction ended on 19.07.16 with a price of €4.03. Massive losses of -43.45% were the result for the BUY prediction by exploration. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - |
| iShares Core DAX® | 1,11 % | 3,98 % | 5,62 % | 49,88 % |
| iShares Nasdaq 100 | 3,27 % | 5,22 % | 41,16 % | 91,99 % |
| iShares Nikkei 225® | 5,78 % | 11,58 % | 64,35 % | 72,79 % |
| iShares S&P 500 | 1,64 % | 2,44 % | 27,36 % | 66,76 % |
Comments by exploration for this prediction
In the thread Ziopharm Oncology diskutieren
Ziopharm: Biotechwerte werden wieder interessant
langfristig werden auch Biotechwerte wieder interessant.
(Stop Loss Kurs erreicht)


